Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study.
Sign Up to like & getrecommendations! Published in 2018 at "Bosnian journal of basic medical sciences"
DOI: 10.17305/bjbms.2017.2279
Abstract: Once-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) may increase patient adherence to treatment but may also be associated with a higher risk of bleeding. In this study, we investigated the adherence to once-… read more here.
Keywords: dosing non; twice daily; study; medication ... See more keywords